Condition
Bronchial Carcinoma
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Unknown2
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06971848Not ApplicableNot Yet Recruiting
Evaluation of Skin Tests in Biotherapy Allergies
NCT04517019Not ApplicableUnknownPrimary
Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy
NCT02270853Not ApplicableUnknown
SAS in Patients With Bronchial Carcinoma
NCT00196885Phase 2Completed
Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training
Showing all 4 trials